Dialysis-Related Amyloidosis Treatment Act of 2024

Hozzl · 2024-12-19T09:05:28Z

Explore the details of House Bill 8999 Dialysis-Related Amyloidosis Treatment Act of 2024 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/19/2024, 9:05 AM

Summary of Bill HR 8999

Bill 118 hr 8999, also known as the Dialysis-Related Amyloidosis Treatment Act of 2024, aims to address the issue of dialysis-related amyloidosis (DRA) by providing funding for research, treatment, and education related to this condition. DRA is a rare but serious complication that can occur in patients undergoing long-term dialysis treatment for kidney failure.

The bill proposes to allocate funds to support research into the causes and potential treatments for DRA, as well as to improve access to specialized care for patients affected by this condition. Additionally, the bill includes provisions for increasing public awareness and education about DRA, in order to help prevent its occurrence and improve outcomes for those who develop the condition.

Overall, the Dialysis-Related Amyloidosis Treatment Act of 2024 seeks to address an important and often overlooked issue in the healthcare system, and to improve the quality of care for patients undergoing dialysis treatment. It represents a bipartisan effort to support research, treatment, and education related to DRA, with the ultimate goal of improving outcomes for patients affected by this condition.

Current Status of Bill HR 8999

Bill HR 8999 is currently in the status of Bill Introduced since July 11, 2024. Bill HR 8999 was introduced during Congress 118 and was introduced to the House on July 11, 2024. Bill HR 8999's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 8999

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8999

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8999

To amend title XVIII of the Social Security Act to provide coverage and payment under such title for certain treatments for dialysis-related amyloidosis, and for other purposes.